Suppr超能文献

胰岛素抵抗、中心性肥胖与结直肠腺瘤风险。

Insulin resistance, central obesity, and risk of colorectal adenomas.

机构信息

Cancer Control and Population Sciences Program, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.

出版信息

Cancer. 2012 Apr 1;118(7):1774-81. doi: 10.1002/cncr.26454. Epub 2011 Aug 25.

Abstract

BACKGROUND

Increasing evidence supports insulin resistance (IR) as the underpinning of the obesity-colorectal neoplasia link. The homeostasis model assessment-IR (HOMA-IR) is a widely accepted index of evolving hyperinsulinemia and early IR. Studies of the relation between HOMA-IR and colorectal adenomas are limited. Therefore, the authors sought to determine the associations of HOMA-IR and central obesity (waist to hip ratio [WHR]) with risk of colorectal adenomas in a screening colonoscopy-based study.

METHODS

The authors collected lifestyle information and fasting blood samples from 1222 participants (320 incident adenoma cases and 902 without adenomas) before their screening colonoscopies. Unconditional logistic regression models were used to assess risk associations.

RESULTS

In multivariate analysis of participants (n = 1093) reporting no antidiabetic medication use, those in the top quartile of WHR were twice as likely (odds ratio [OR], 2.18; 95% confidence interval [CI], 1.33-3.57; P-trend = .003) and those in the top quartile of HOMA-IR were 63% more likely (OR, 1.63; 95% CI, 1.09-2.44; P-trend = .01) to have adenomas compared with those in the bottom quartiles. Stratified analysis revealed a statistically significant interaction between HOMA-IR and sex (P-interaction = .04), with the association largely limited to men; compared with those in the bottom tertile, men in the top tertile of HOMA-IR were twice more likely to have adenomas (OR, 2.11; 95% CI, 1.18-3.78; P-trend = .01).

CONCLUSIONS

The results support central obesity and insulin resistance, particularly in men, as important risk factors for the development of early colorectal neoplasia.

摘要

背景

越来越多的证据表明,胰岛素抵抗(IR)是肥胖与结直肠肿瘤之间关联的基础。稳态模型评估-胰岛素抵抗(HOMA-IR)是一种广泛接受的胰岛素血症和早期胰岛素抵抗的指标。关于 HOMA-IR 与结直肠腺瘤之间关系的研究有限。因此,作者试图在基于筛查结肠镜的研究中确定 HOMA-IR 和中心性肥胖(腰围与臀围比[WHR])与结直肠腺瘤风险之间的关系。

方法

作者在筛查结肠镜检查前,从 1222 名参与者(320 例新发腺瘤病例和 902 例无腺瘤病例)中收集了生活方式信息和空腹血样。使用非条件逻辑回归模型评估风险关联。

结果

在报告未使用抗糖尿病药物的参与者(n=1093)的多变量分析中,WHR 最高四分位组发生腺瘤的可能性是最低四分位组的两倍(比值比[OR],2.18;95%置信区间[CI],1.33-3.57;P 趋势=.003),HOMA-IR 最高四分位组发生腺瘤的可能性是最低四分位组的 63%(OR,1.63;95% CI,1.09-2.44;P 趋势=.01)。分层分析显示 HOMA-IR 与性别之间存在统计学显著交互作用(P 交互=.04),该关联主要限于男性;与 HOMA-IR 最低三分位组相比,HOMA-IR 最高三分位组的男性发生腺瘤的可能性是前者的两倍(OR,2.11;95% CI,1.18-3.78;P 趋势=.01)。

结论

研究结果支持中心性肥胖和胰岛素抵抗,尤其是在男性中,作为结直肠早期肿瘤发展的重要危险因素。

相似文献

6
Insulin resistance, apoptosis, and colorectal adenoma risk.胰岛素抵抗、细胞凋亡与结肠直肠腺瘤风险。
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2076-81. doi: 10.1158/1055-9965.EPI-05-0239.

引用本文的文献

5
Obesity-Associated Colorectal Cancer.肥胖相关性结直肠癌。
Int J Mol Sci. 2024 Aug 14;25(16):8836. doi: 10.3390/ijms25168836.
8
Young Adult Cancer: Influence of the Obesity Pandemic.青年癌症:肥胖大流行的影响。
Obesity (Silver Spring). 2018 Apr;26(4):641-650. doi: 10.1002/oby.22137.

本文引用的文献

7
Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.代谢综合征组分与 CLUE II 队列中的结直肠腺瘤。
Cancer Causes Control. 2010 Jan;21(1):1-10. doi: 10.1007/s10552-009-9428-6. Epub 2009 Sep 23.
9
Components of metabolic syndrome and metachronous colorectal neoplasia.代谢综合征与异时性结直肠肿瘤的组成部分。
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1134-43. doi: 10.1158/1055-9965.EPI-08-1015. Epub 2009 Mar 24.
10
Metabolic syndrome and cancer.代谢综合征与癌症。
Metab Syndr Relat Disord. 2009 Aug;7(4):279-88. doi: 10.1089/met.2008.0065.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验